Literature DB >> 10567490

Clinical and radiological determinants of prestroke cognitive decline in a stroke cohort.

T Pohjasvaara1, R Mäntylä, H J Aronen, M Leskelä, O Salonen, M Kaste, T Erkinjuntti.   

Abstract

OBJECTIVES: Stroke seems to be related to dementia more often than previously assumed and vascular factors are also related to Alzheimer's disease. The pathophysiology of poststroke dementia includes ischaemic changes in the brain, a combination of degenerative and vascular changes, and changes only related to Alzheimer's disease. Some cognitive decline recognised after a stroke may be due to pre-existing cognitive decline. The aim of this study was to determine the clinical and radiological determinants of prestroke cognitive decline.
METHODS: The study group comprised 337 of 486 consecutive patients aged 55 to 85 years who 3 months after ischaemic stroke completed a comprehensive neuropsychological test battery; structured medical, neurological, and mental status examination; interview of a knowledgeable informant containing structured questions on abnormality in the cognitive functions; assessment of social functions before the index stroke; and MRI.
RESULTS: Frequency of prestroke cognitive decline including that of dementia was 9.2% (31/337). The patients with prestroke cognitive decline were older, more often had less than 6 years of education, and had history of previous stroke. Vascular risk factors did not differ significantly between these two groups. White matter changes (p=0.004), cortical entorhinal, hippocampal, and medial temporal atrophy (p<0.001), cortical frontal atrophy (p=0.008); and any central atrophy (p<0.01), but not the frequencies or volumes of old, silent, or all infarcts on MRI differentiated those with and without prestroke cognitive decline. The correlates of prestroke cognitive decline in logistic regression analysis were medial temporal cortical atrophy (odds ratio (OR) 7.5, 95% confidence interval (95%CI) 3.2-18.2), history of previous ischaemic stroke (OR 4.4, 95% CI 1.8-10.6), and education (OR 0.9, 95% CI 0.8-0.9).
CONCLUSIONS: History of previous stroke, but not volumes or frequencies was found to correlate with prestroke cognitive decline. Other associating factors were rather those usually associated with degenerative dementia: white matter changes and cerebral atrophy; and in multiple models medial temporal cortical atrophy and education. The possible overlap between two or more underlying diseases must be remembered in diagnosis and treatment of patients with vascular cognitive impairment.

Entities:  

Mesh:

Year:  1999        PMID: 10567490      PMCID: PMC1736686          DOI: 10.1136/jnnp.67.6.742

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  43 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  A semi-structured clinical interview for the assessment of diagnosis and mental state in the elderly: the Geriatric Mental State Schedule. I. Development and reliability.

Authors:  J R Copeland; M J Kelleher; J M Kellett; A J Gourlay; B J Gurland; J L Fleiss; L Sharpe
Journal:  Psychol Med       Date:  1976-08       Impact factor: 7.723

3.  The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.

Authors:  G Blessed; B E Tomlinson; M Roth
Journal:  Br J Psychiatry       Date:  1968-07       Impact factor: 9.319

4.  Progress in development of the index of ADL.

Authors:  S Katz; T D Downs; H R Cash; R C Grotz
Journal:  Gerontologist       Date:  1970

Review 5.  Clinical and neuropsychological assessment of dementia.

Authors:  F A Huppert; E Tym
Journal:  Br Med Bull       Date:  1986-01       Impact factor: 4.291

Review 6.  Cerebral amyloid angiopathy. A critical review.

Authors:  H V Vinters
Journal:  Stroke       Date:  1987 Mar-Apr       Impact factor: 7.914

7.  Measurement of functional activities in older adults in the community.

Authors:  R I Pfeffer; T T Kurosaki; C H Harrah; J M Chance; S Filos
Journal:  J Gerontol       Date:  1982-05

8.  A new clinical scale for the staging of dementia.

Authors:  C P Hughes; L Berg; W L Danziger; L A Coben; R L Martin
Journal:  Br J Psychiatry       Date:  1982-06       Impact factor: 9.319

9.  Dementia in stroke survivors in the Stroke Data Bank cohort. Prevalence, incidence, risk factors, and computed tomographic findings.

Authors:  T K Tatemichi; M A Foulkes; J P Mohr; J R Hewitt; D B Hier; T R Price; P A Wolf
Journal:  Stroke       Date:  1990-06       Impact factor: 7.914

10.  A new method of measuring brain atrophy: the effect of aging in its application for diagnosing dementia.

Authors:  M S Yerby; J W Sundsten; E B Larson; S A Wu; S M Sumi
Journal:  Neurology       Date:  1985-09       Impact factor: 9.910

View more
  10 in total

1.  Changes in memory before and after stroke differ by age and sex, but not by race.

Authors:  Qianyi Wang; Iván Mejía-Guevara; Pamela M Rist; Stefan Walter; Benjamin D Capistrant; M Maria Glymour
Journal:  Cerebrovasc Dis       Date:  2014-03-25       Impact factor: 2.762

Review 2.  Poststroke dementia in the elderly.

Authors:  Marie-Anne Mackowiak-Cordoliani; Stéphanie Bombois; Armelle Memin; Hilde Hénon; Florence Pasquier
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 3.  Stroke and cognition.

Authors:  R N Kalaria; C Ballard
Journal:  Curr Atheroscler Rep       Date:  2001-07       Impact factor: 5.113

Review 4.  Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association.

Authors:  Philip B Gorelick; Angelo Scuteri; Sandra E Black; Charles Decarli; Steven M Greenberg; Costantino Iadecola; Lenore J Launer; Stephane Laurent; Oscar L Lopez; David Nyenhuis; Ronald C Petersen; Julie A Schneider; Christophe Tzourio; Donna K Arnett; David A Bennett; Helena C Chui; Randall T Higashida; Ruth Lindquist; Peter M Nilsson; Gustavo C Roman; Frank W Sellke; Sudha Seshadri
Journal:  Stroke       Date:  2011-07-21       Impact factor: 7.914

5.  Characteristics of MR infarcts associated with dementia and cognitive function in the elderly.

Authors:  Neelum T Aggarwal; Julie A Schneider; Robert S Wilson; Todd L Beck; Denis A Evans; Charles De Carli
Journal:  Neuroepidemiology       Date:  2011-12-17       Impact factor: 3.282

Review 6.  Stroke-related dementia.

Authors:  José G Merino; Vladimir Hachinski
Journal:  Curr Atheroscler Rep       Date:  2002-07       Impact factor: 5.113

7.  Cognitive impairment and functional outcome after stroke associated with small vessel disease.

Authors:  V C T Mok; A Wong; W W M Lam; Y H Fan; W K Tang; T Kwok; A C F Hui; K S Wong
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-04       Impact factor: 10.154

8.  Mild cognitive impairment and event-related potentials in patients with cerebral atrophy and leukoaraiosis.

Authors:  Ryszard Podemski; Anna Pokryszko-Dragan; Mieszko Zagrajek; Krzysztof Słotwiński; Małgorzata Bilińska; Marek Sasiadek; Jacek Filarski; Katarzyna Mazur
Journal:  Neurol Sci       Date:  2008-12-05       Impact factor: 3.307

9.  Impact of post-stroke cognitive impairment with no dementia on health-related quality of life.

Authors:  Jung Hyun Park; Beom Joon Kim; Hee-Joon Bae; Jisung Lee; Juneyoung Lee; Moon-Ku Han; Kyung Yoon O; Seong Ho Park; Yeonwook Kang; Kyung-Ho Yu; Byung-Chul Lee
Journal:  J Stroke       Date:  2013-01-31       Impact factor: 6.967

10.  Cognitive Impairment Before Atrial Fibrillation-Related Ischemic Events: Neuroimaging and Prognostic Associations.

Authors:  Gargi Banerjee; Edgar Chan; Gareth Ambler; Duncan Wilson; Lisa Cipolotti; Clare Shakeshaft; Hannah Cohen; Tarek Yousry; Rustam Al-Shahi Salman; Gregory Y H Lip; Keith W Muir; Martin M Brown; Hans Rolf Jäger; David J Werring
Journal:  J Am Heart Assoc       Date:  2020-01-04       Impact factor: 5.501

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.